Auransa Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Auransa General Information

Description

Developer of a biology-first AI platform designed to discover novel therapeutics using human disease data. The company offers a proprietary data-driven discovery engine that analyzes large-scale gene expression datasets and clinical insights, enabling oncology research teams to identify targeted therapies and advance precision medicine programs.

Contact Information

Website
www.auransa.com
Formerly Known As
CapellaBio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1726 Edgewood Drive
  • Palo Alto, CA 94303
  • United States
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 1726 Edgewood Drive
  • Palo Alto, CA 94303
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Auransa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 04-Jan-2023 Completed Clinical Trials - General
4. Later Stage VC (Series A) 15-Oct-2021 Completed Clinical Trials - General
3. Early Stage VC (Series A) 31-May-2017 Completed Pre-Clinical Trials
2. Seed Round 22-Dec-2014 $2.81M $2.81M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Auransa’s complete valuation and funding history, request access »

Auransa Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A4
Series A3
Series A2
Series A1
Series A 3,019,703 $0.000100 $0.37 $4.68 $4.68 1x $4.68 16.49%
Seed 2,810,000 $0.000100 $0.08 $1 $1 1x $1 15.34%
To view Auransa’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Auransa Patents

Auransa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025189166-A1 Pharmaceutical compounds for treatment of bipolar disorder Pending 07-Mar-2024
WO-2025189166-A8 Pharmaceutical compounds for treatment of bipolar disorder Pending 07-Mar-2024
EP-4688745-A2 Pentamidine analogue polymorphs, formulations, and methods thereof Pending 07-Apr-2023
US-20260274798-A1 Pentamidine analogue polymorphs, formulations, and methods thereof Pending 07-Apr-2023
WO-2024211870-A2 Pentamidine analogue polymorphs, formulations, and methods thereof Inactive 07-Apr-2023 C07D213/81
To view Auransa’s complete patent history, request access »

Auransa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Auransa Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Harmonix Fund Venture Capital Minority
11.2 Capital Venture Capital Minority
AME Cloud Ventures Venture Capital Minority
DCVC Venture Capital Minority
Lux Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Auransa FAQs

  • When was Auransa founded?

    Auransa was founded in 2014.

  • Where is Auransa headquartered?

    Auransa is headquartered in Palo Alto, CA.

  • What is the size of Auransa?

    Auransa has 11 total employees.

  • What industry is Auransa in?

    Auransa’s primary industry is Discovery Tools (Healthcare).

  • Is Auransa a private or public company?

    Auransa is a Private company.

  • What is Auransa’s current revenue?

    The current revenue for Auransa is .

  • How much funding has Auransa raised over time?

    Auransa has raised $26.5M.

  • Who are Auransa’s investors?

    Harmonix Fund, 11.2 Capital, AME Cloud Ventures, DCVC, and Lux Capital are 5 of 7 investors who have invested in Auransa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process